Cookies help us deliver our services. By using our services you agree to our use of cookiesDetails Ok CONTACTS WORKING AT IBI PRIVATE AREA ENG ITA MENU 100 years of quality products and services 1234 A VERTICALLY INTEGRATED COMPANY IBI, IBIGEN group, is a company that has been producing and selling injectable products all over the world for 100 years. It is also present in hospitals (Parental Products for Hospitals). Expert in aseptic dosing and ß-lactam products, it is a vertical company working from the raw material through the finished product to sales distribution and the patient’s bed. FOCUS ON ANTIBIOTIC TREATMENTS IBI has a long tradition and is specialized in the production of injectable sterile penicillin, which it exports all over the world. The IBI line of antibiotics includes various other products belonging to the classes of cephalosporins, quinolones, aminoglycosides and lincosamides. Enter FOCUS ON GASTRONENTEROLOGY IBI is present in gastroenterology, since the 1970s, with products for therapy related to abdominal pathology, such as dyspepsia, cholelithiasis, cholestasis and other chronic hepatopathies such as steatosis and Non-Alcoholic Liver Disease (NAFLD), to the treatment of gastrointestinal symptoms with products for the improvement of peristalsis, meteorism and constipation. Enter OPEN INNOVATION IBI has always been committed to the discovery, development and sale of innovative products and is now concentrated on the industry 4.0 challenge. In Europe it is a partner in the development of new therapy protocols, such as the EU nanomedicine project B-SMART, and it offers its experience to research centres and universities to create complex drugs and innovative therapies. Enter EXPORT 20 COUNTRIES 300 EMPLOYERS 4 BRANCHES 18.000 MQ PRODUCTION PLANT AIFA, FDA, EDQM, TGA certificates SCIENTIFIC TRADITION AND INNOVATION IBI, IBIGEN Group, produces cGMP penicillins in oral and injectable forms. The continuous research and innovative technologies make the company an excellence in Italian pharmaceuticals and place it amongst the top 10 Italian companies in the production of various molecules for third party. Enter Export Enter Hospitals Hospital in Italy Hospitals in Germany Hospitals in United Kingdom Pharmacy Enter LATEST NEWS REVER3MAB: "An ambitious project for the development of an innovative biological drug"? IBI collaborates in the development of an innovative biological drug to revert resistance to conventional cancer treatments: project: REVER3MAB (EU, State and Region) Read all Seguiamo i farmaci fino a voi Cinquanta milioni di investimento digitale e un forte impegno nella tracciabilità dei prodotti Read all Industry Experts Combine to Create Safer Intravenous Delivery The Italian Biochemical Institute, Comecer, and Particle Measuring Systems share expertise to develop and manufacture a safer intravenous solution. Read all See all news items Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. Via Fossignano, 2 Aprilia (LT), 04011 Italy. VAT Nr. 02578030153 T +39.06.92150.1 • F +39.06.92150.500 • @ info@ibi-lorenzini.com The Data Protection Officer (DPO) contacts are: dpo_ibi@protectiontrade.it Employees area privacy cookies IBIGEN Pharmaceutical Group Terapeutical Solutions Development and Production IBI News Contacts Working at IBI Pharmacovigilance ?>